OTC: NWBO - Northwest Biotherapeutics, Inc.

Yield per half year: -30%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Northwest Biotherapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors.

more details
The company was founded in 1996 and is headquartered in Bethesda, Maryland.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

ISIN US66737P6007
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.nwbio.com
Цена ао 0.23
Change price per day: -3.45% (0.2175)
Change price per week: +10.53% (0.19)
Change price per month: -16% (0.25)
Change price per 3 month: -19.23% (0.26)
Change price per half year: -30% (0.3)
Change price per year: -58.82% (0.51)
Change price per 3 year: -77.66% (0.94)
Change price per 5 year: +48.83% (0.1411)
Change price per year to date: -25% (0.28)
All parameters

Underestimation

Title Value Grade
P/S 456.31 1
P/BV -13.4 0
P/E 0 0
EV/EBITDA -9.03 0
Total: 2

Efficiency

Title Value Grade
ROA, % -224.65 0
ROE, % 95.17 10
Total: 1.67

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.4184 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % -19.5 0
Yield Ebitda, % 296.2 10
Yield EPS, % 61.38 8
Total: 7.2
More

Institutions Volume Share, %
Moloney Securities Asset Management, LLC 358160 0.03
Opus Capital Group, LLC 60150 0.01
Williams Jones Wealth Management, LLC. 44000 0
Lee, Danner & Bass, Inc. 20000 0
MAI Capital Management 20000 0
Advisors Management Group, Inc. 10270 0
Bartlett & Co. 4292 0
Bartlett & Co. Wealth Management LLC 4292 0
Coston, McIsaac & Partners 1000 0



Head Job title Payment Year of birth
Ms. Linda F. Powers J.D. Chairperson, CEO, President, CFO & Chief Accounting Officer 925k 1956 (69 years)
Dr. Alton L. Boynton Ph.D. Founder, Chief Scientific Officer, Secretary & Director 375k 1945 (80 years)
Dr. Marnix L. Bosch M.B.A., Ph.D. Chief Technical Officer 453.6k 1959 (66 years)
Mr. Leslie J. Goldman Senior VP & General Counsel 725k 1945 (80 years)
Mr. David Innes Vice President of Investor Relations N/A

Address: United States, Bethesda. MD, 4800 Montgomery Lane - open in Google maps, open in Yandex maps
Website: https://www.nwbio.com